TLR4 signaling promotes immune escape of human colon cancer cells by inducing immunosuppressive cytokines and apoptosis resistance

Oncology Research

Volumn 20, Issue 1, 2012, Pages 15-24

  Tang, Xiaoyan ^a   Zhu, Youqing ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Apoptosis resistance; Colon cancer; Immune escape; TLR4

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; VASCULOTROPIN;

APOPTOSIS; ARTICLE; CANCER CELL; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; COLON CANCER; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 84865453565     PISSN: 09650407     EISSN: 15553906     Source Type: Journal    
DOI: 10.3727/096504012X13425470196092     Document Type: Article

References (31)

1. Medzhitov, R.; Preston-Hurlburt, P.; Janeway, Jr., C. A. A human homologue of the Drosophila Toll proteins signals activation of adaptive immunity. Nature 388:394-739; 1997.
2. Takeda, K.; Kaisho, T.; Akira, S. Toll-like receptors. Annu. Rev. Immunol. 21:335-376; 2003.
3. Zhang, Z.; Schluesener, H. J. Mammalian toll-like receptors: From endogenous ligands to tissue regeneration. Cell. Mol. Life Sci. 63:2901-2907; 2006.
4. Chen, K. Q.; Huang, J.; Gong, W. H.; Iribarren, P.; Dunlop, N. M.; Wang, J. M. Toll-like receptors in inflammation, infection and cancer. Int. Immunopharmacol. 7: 1271-1285; 2007.
5. Kawai, T.; Akira, S. Pathogen recognition with Toll-like receptors. Curr. Opin. Immunol. 17:338-344; 2005.
6. Biragyn, A.; Ruffini, P. A.; Leifer, C. A.; Klyushnenkova, E.; Shakhov, A.; Chertov, O. Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science 298:1025-1029; 2002.
7. Guillot, L.; Balloy, V.; McCormack, F. X.; Golenbock, D. T.; Chignard, M.; Si-Tahar, M. Cutting edge: The immunostimulatory activity of the lung surfactant protein-A involves Toll-like receptor 4. J. Immunol. 168:5989-5992; 2004.
8. Mittal, D.; Saccheri, F.; Vénéreau, E.; Pusterla, T.; Marco, E.; Bianchi, M. E.; Rescigno, M. TLR4-mediated skin carcinogenesis is dependent on immune and radioresistant cells. EMBO J. 29:2242-2252; 2010.
9. Lancaster, G. I.; Khan, Q.; Drysdale, P.; Wallace, F.; Jeukendrup, A. E.; Mark, T.; Drayson, M. T. The physiological regulation of toll like receptor expression and function in humans. J. Physiol. 563(Pt. 3):945-955; 2005.
10. Yu, L.; Wang, L.; Li, M.; Zhong, J. M.; Wang, Z.; Chen, S. W. Expression of toll-like receptor 4 is down-regulated during progression of cervical neoplasia. Cancer Immunol. Immunother. 59:1021-1028; 2010.
11. González-Reyes, S.; Fernández, J. M.; González, L. O.; Aguirre, A.; Suárez, A.; González, J. M. Study of TLR3, TLR4, and TLR9 in prostate carcinomas and their association with biochemical recurrence. Cancer Immunol. Immunother. 60:217-226; 2011.
12. Nomi, N.; Kodama, S.; Suzuki, M. Toll-like receptor 3 signaling induces apoptosis in human head and neck cancer via survivin associated pathway. Oncol. Rep. 24:225-231; 2010.
13. Huang, B.; Zhao, J.; Li, H. Toll-like receptors on tumor cells facilitate evasion of immune surveillance. Cancer Res. 65:5009-5014; 2005.
14. Nihon-yanagi, Y.; Park, Y.; Ooshiro, M.; Terai, K.; Matsumoto, T.; Murano, T. Expression of toll-like receptor 4 in colorectal cancer. Gan To Kagaku Ryoho 35: 2247-2249; 2008.
15. Kawai, T.; Akira, S. TLR signaling. Semin. Immunol. 19: 24-32; 2007.
16. Fang, J. Y.; Richardson, B. C. The MAPK signalling pathways and colorectal cancer. Lancet Oncol. 6:322-327; 2005.
17. Piotrowska, A.; Izykowska, I.; Podhorska-Okolow, M.; Zabel, M.; Dziegiel, P. The structure of NF- kappaB family proteins and their role in apoptosis. Postepy Hig Med Dosw. 62:64-74; 2008.
18. Abreu, M. T.; Arnold, E. T.; Thomas, L. S.; Gonsky, R.; Zhou, Y.; Hu, B. TLR4 and MD-2 expression is regulated by immune-mediated signals in human intestinal epithelial cells. J. Biol. Chem. 277:20431-20437; 2008.
19. Hofmanová, J.; Vaculová, A.; Hyzd'alová, M.; Kozubík, A. Response of normal and colon cancer epithelial cells to TNF-family apoptotic inducers. Oncol. Rep. 19:567-573; 2008.
20. Lin, W. W.; Karin, M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J. Clin. Invest. 117:1175-1183; 2007.
21. Hofseth, L. J.; Wargovich, M. J. Inflammation, cancer, and targets of ginseng. J. Nutr. 137(1 Suppl.):183s-185s; 2007.
22. Vicari, A. P.; Caux, C.; Trinchieri, G. Tumor escape from immune surveillance through dendritic cell inactivation. Semin. Cancer Biol. 12:33-42; 2002.
23. Re, F.; Strominger, J. L. Heterogeneity of TLR-induced responses in dendritic cells: From innate to adaptive immunity. Immunobiology 209:191-198; 2004.
24. Akira, S.; Takeda, K.; Kaisho, T. Toll-like receptors: Critical proteins linking innate and acquired immunity. Nat. Immunol. 2:675-680; 2001.
25. Yang, L.; Pang, Y.; Moses, H. L. TGF-beta and immune cells: An important regulatory axis in the tumor microenvironment and progression. Trends Immunol. 31:220-227; 2010.
26. Di Domenico, M.; Ricciardi, C.; Fusco, A.; Pierantoni Giovanna, M. Anti-VEGF therapy in breast and lung mouse models of cancers. J. Biomed. Biotechnol. 928-947; 2011.
27. Igney, F. H.; Krammer, P. H. Immune escape of tumors: apoptosis resistance and tumor counterattack. J. Leukoc. Biol. 71:907-920; 2007.
28. Melnikova, V. O.; Bar-Eli, M. Bioimmunotherapy for melanoma using fully human antibodies targeting MCAM/MUC18 and IL-8. Pigment Cell Res. 19:395-405; 2006.
29. Barkett, M.; Gilmore, T. D. Control of apoptosis by Rel/ NF-kB transcription factors. Oncogene 18:6910-6924; 1999.
30. Kelly, M. G.; Alvero, A. B.; Chen, R.; Silasi, D. A.; Abrahams, V. M.; Chan, S. TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer. Cancer Res. 66:3859-3868; 2006.
31. Vabulas, R. M.; Wagner, H.; Schild, H. Heat shock proteins as ligands of toll-like receptors. Curr. Top. Microbiol. Immunol. 270:169-184; 2002.